InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Aliski William, 董事. Director active across 3 companies, notably Ultragenyx Pharmaceutical Inc.. Cumulatively, 5 filings have been recorded. History available since 24 June 2021. The latest transaction was disclosed on 10 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Aliski William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
45,000 股0Common StockSEC:0001628280-24-027677:0
45,000 股0Common StockSEC:0001628280-23-022099:0
8,500 股Common StockSEC:0001062993-22-023027:0
6,667 股0Common StockSEC:0001628280-22-018048:0
2,145 股0Common StockSEC:0001209191-21-043547:0
5 条申报中的 5 条
About Aliski William
William Aliski is a Board Member at Ultragenyx Pharmaceutical Inc. He brings his expertise in corporate governance and strategy to the leadership team. Ultragenyx is dedicated to discovering and developing treatments for rare diseases. As a Board Member, William Aliski plays a key role in the strategic direction of the company, ensuring it remains aligned with its research and development goals.
